Globalstar, Inc Common Stock (GSAT) had the highest return in 2013 by a large-cap US stock, returning 446.9%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Globalstar, Inc Common Stock (GSAT) | 2013 | 446.88% |
Arrowhead Pharmaceuticals (ARWR) | 2013 | 402.31% |
Tesla (TSLA) | 2013 | 329.81% |
Netflix (NFLX) | 2013 | 286.71% |
Ionis Pharmaceuticals (IONS) | 2013 | 274.79% |
Ubiquiti Networks (UI) | 2013 | 267.97% |
Alnylam Pharmaceuticals (ALNY) | 2013 | 239.31% |
Best Buy (BBY) | 2013 | 235.98% |
Micron Technology (MU) | 2013 | 229.55% |
Incyte (INCY) | 2013 | 202.81% |
Everpure (P) | 2013 | 182.98% |
Genmab A-S (GMAB) | 2013 | 179.57% |
AerCap (AER) | 2013 | 175.9% |
Diamondback Energy (FANG) | 2013 | 171.74% |
DexCom (DXCM) | 2013 | 154.93% |
Insmed (INSM) | 2013 | 152.23% |
Vicor (VICR) | 2013 | 147.6% |
Jazz Pharmaceuticals (JAZZ) | 2013 | 132.95% |
Delta Air Lines (DAL) | 2013 | 128.76% |
Cheniere Energy (LNG) | 2013 | 126.95% |
YPF Sociedad Anonima (YPF) | 2013 | 119.01% |
TKO (TKO) | 2013 | 117.31% |
Corpay (CPAY) | 2013 | 114.75% |
Corcept Therapeutics (CORT) | 2013 | 111.18% |
Trip Group Ltd ADR (TCOM) | 2013 | 111.15% |
Large-cap stocks are treated as having a market cap of $10B+.